• Publications Search
• Publications Policy
• Journal Summary
• Worldwide Publications Summary
• Editorials

ISAAC publications of worldwide analyses

ISAAC PhaseOne Publications (worldwide)

1.0 Preliminary Papers

• 1.1 ISAAC. ISAAC Manual (2nd Edition). Auckland/Münster.December 1993.
• | View full article

• 1.2 Pearce N, Weiland S, Keil U, Langridge P, Anderson HR, Strachan D, Bauman A, Young L, Gluyas P, Ruffin D, Crane J, Beasley R. Self-reported prevalence of asthma symptoms in children in Australia, England, Germany and New Zealand: an international comparison using the ISAAC protocol. Eur Respir J 1993; 6: 1455-61.
• View Abstract | View full article [263 citations]

• 1.3 Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, Strachan D, Weiland SK, Williams HC. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-91.
• View Abstract | View full article [1104 citations]

2.0 Main Findings

• 2.1 Strachan D, Sibbald B, Weiland S, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Robertson C, Shah J, Stewart A, von Mutius E, Williams H. Worldwide Variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997; 8(4): 161-76.
• View Abstract | View full article [264 citations]

• 2.2 The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351(9111): 1225-32.
• View Abstract | View Journal page | View Editorial [1717 citations]

• 2.3 Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson HR, Asher MI, Beasley R, Björkstén B, Burr M, Clayton T, Crane J, Ellwood P, Keil U, Lai C, Mallol J, Martinez F, Mitchell E, Montefort S, Pearce N, Shah J, Sibbald B, Strachan D, von Mutius E, Weiland S. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999; 103(1 Pt 1): 125-38.
• View Abstract | View full article [359 citations]

• 2.4 The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12(2): 315-335.
• View Abstract | View full article [580 citations]

3.0 Other Overview Papers

• 3.1 Asher MI, Weiland SK, on behalf of the ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 1998; 28 Suppl 5: 52-66.
• View Abstract | View full article [112 citations]

• 3.2 Beasley R, Ellwood P, Asher I. International patterns of the prevalence of pediatric asthma the ISAAC program. Pediatr Clin North Am 2003; 50(3): 539-53.Copyright© Elsevier 2003.
• View Abstract | View Article | Journal Homepage [42 citations]

• 3.3 Lai C, Pearce N. The contribution of ISAAC to the understanding of asthma. Leukotriene Res & Clin Rev 2001; 2: 1-4.
• View Abstract | View full article

• 3.4 Mallol J, Asher MI, Williams H, Clayton T, Beasley R on behalf of the ISAAC Steering Committee. ISAAC findings in children aged 14 years: an overview. Allergy Clin Immunol Int 1999; 11: 176-82.
• View Abstract | View full article

• 3.5 von Mutius E. Epidemiology of asthma: ISAAC--International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 1996; 7(9 Suppl): 54-6.
• View Abstract | View full article [6 citations]

4.0 Ecological Analyses

• 4.1 Anderson HR, Gupta R, Kapetanakis V, Asher MI, Clayton T, Robertson CF, Strachan DP, and the ISAAC Steering Committee. International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. Int J Epidemiol 2008; 37(3):573-82.
• View Abstract | View full article [9 citations]

• 4.2 Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Björkstén B, Asher MI, and the ISAAC Phase One Study Group. Immunization and symptoms of atopic disease in children: Results from the International Study of Asthma and Allergies in Childhood. Am J Publ Health 2001; 91(7): 1126-9.
• View Abstract | View full article [68 citations]

• 4.3 Burr ML, Emberlin JC, Treu R, Cheng S, Pearce NE, and the ISAAC Phase One Study Group. Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003; 33(12): 1675-80.
• View Abstract | View full article [33 citations]

• 4.4 Ellwood P, Asher MI, Björkstén B, Burr M, Pearce N, Robertson CF, and the ISAAC Phase One Study Group. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: An ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. Eur Respir J 2001; 17(3): 436-443.
• View Abstract | View full article [88 citations]

• 4.5 Foliaki S, Kildegaard Nielsen S, Björkstén B, von Mutius E, Cheng S, Pearce N, and the ISAAC Phase One Study Group. Antibiotic sales and the prevalence of symptoms of asthma, rhinitis, and eczema: The International Study of Asthma and Allergies in Childhood (ISAAC). Int J Epidemiol 2004; 33(3): 558-63.
• View Abstract | View full article [24 citations]

• 4.6 Mitchell EA, Stewart AW, on behalf of the ISAAC Phase One Study Group. The ecological relationship of tobacco smoking to the prevalence of symptoms of asthma and other atopic diseases in children: The International Study of Asthma and Allergies in Childhood (ISAAC). Eur J Epidemiol 2001; 17(7): 667-73.
• View Abstract | View full article [19 citations]

• 4.7 Shirtcliffe P, Weatherall M, Beasley R, on behalf of the ISAAC Phase One Study Group. An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology 2002; 7(2): 153-5.
• View Abstract | View Journal page [18 citations]

• 4.8 Stewart AW, Mitchell EA, Pearce N, Strachan DP, Weiland SK, on behalf of the ISAAC Steering Committee. The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol 2001; 30: 173-9.
• View Abstract | View full article [66 citations]

• 4.9 von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Björkstén B, Weiland S, on behalf of the ISAAC Steering Committee. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis and eczema. Thorax 2000; 55(6): 449-453.
• View Abstract | View full article [112 citations]

• 4.10 Weiland SK, von Mutius E, Hüsing A, Asher MI, on behalf of the ISAAC Steering Committee. Intake of trans fatty acids and prevalence of childhood asthma and allergies in Europe. Lancet 1999; 353(9169): 2040-1.
• View Abstract | View Journal page [92 citations]

• 4.11 Weiland SK, Hüsing A, Strachan D, Rzehak P, Pearce N, and the ISAAC Phase One Study Group. Climate and the prevalence of symptoms of asthma, allergic rhinitis and atopic eczema in children. Occup Environ Med 2004; 61(7): 609-15.
• View Abstract | View full article [70 citations]

• 4.12 Anderson HR, Ruggles R, Pandey KD, Kapetenakis V, Brunekreef B, Lai CKW, Strachan DP, Weiland SK, and the ISAAC Phase One Study Group. Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med 2010; 67(5): 293-300. doi:10.1136/oem.2009.048785. epub: 9 October 2009.
• View Abstract | View Journal page [1 citations]

• 4.13 Asher MI, Stewart AW, Mallol J, Montefort M, Lai CKW, Aït-Khaled N, Odhiambo J, and the ISAAC Phase One Study Group. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? A review of the ecological analyses of ISAAC Phase One. Respiratory Research. 2010; 11(8):
• View Abstract | View full article [5 citations]

5.0 Other Papers

• 5.1 Crane J, Mallol J, Beasley R, Stewart A, Asher MI, on behalf of the ISAAC Phase One Study Group. Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J 2003; 21(3): 455-61.
• View Abstract | View full article [45 citations]

• 5.2 Pearce N, Sunyer J, Cheng S, Chinn S, Björkstén B, Burr M, Keil U, Anderson HR, Burney P, on behalf of the ISAAC Steering Committee and the European Community Respiratory Health Survey. Comparison of asthma prevalence in the ISAAC and the ECRHS. Eur Respir J 2000; 16(3): 420-6.
• View Abstract | View full article [93 citations]

ISAAC PhaseTwo Publications (worldwide)

1.0 Preliminary Papers

• 1.1 ISAAC. ISAAC Phase II Modules. Münster, Germany.May 1998.
• | View full article

• 1.2 von Mutius E, Weiland SK, Keil U and the ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): study design and methods of phase II. Allergologie 1999; 22(5):283-288.
• View Abstract | View full article [1 citations]

• 1.3 Weiland SK, von Mutius E, Keil U, on behalf of the ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): rational methods and outlook. Allergologie 1999; 22(5):275-282.
• View Abstract | View full article [3 citations]

• 1.4 Weiland SK, Björkstén B, Brunekreef B, Cookson WO, von Mutius E, Strachan DP, and the ISAAC Phase Two Study Group. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J 2004; 24(3): 406-12.
• View Abstract | View full article [123 citations]

2.0 Main Findings

• 2.1 Weinmayr G, Weiland SK, Björkstén B, Brunekreef B, Büchele G, Cookson WO, García-Marcos L, Gotua M, Gratziou C, van Hage M, von Mutius E, Riikjärv MA, Rzehak P, Stein RT, Strachan DP, Tsanakas J, Wickens K, Wong GW, and the ISAAC Phase Two Study Group. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176(6): 565-74.
• View Abstract | View full article [85 citations]

• 2.2 Flohr C, Weiland SK, Weinmayr G, Björkstén B, Bråbäck L, Brunekreef B, Büchele G, Clausen M, Cookson WOC, von Mutius E, Strachan DP, Williams HC, and the ISAAC Phase Two Study Group. The role of atopic sensitization in flexural eczema: Findings from the International Study of Asthma and Allergies in Childhood Phase Two. J Allergy Clin Immunol 2008; 121(1): 141-7.
• View Abstract | View full article [26 citations]

• 2.3 Weinmayr G, Forastiere F, Weiland SK, Rzehak P, Abramidze T, Annesi-Maesano I, Björkstén B, Brunekreef B, Büchele G, Cookson WO, von Mutius E, Pistelli R, Strachan DP, and the ISAAC Phase Two Study Group. International variation in prevalence of rhinitis and its relation with sensitization to perennial and seasonal allergens. Eur Respir J 2008; 32: 1250–1261.
• View Abstract | View full article [16 citations]

• 2.4 Gehring U, Strikwold M, Schram-Bijkerk D, Weinmayr G, Genuneit J, Nagel G, Wickens K, Siebers R, Crane J, Doekes G, Di Domenicantonio R, Nilsson L, Priftanji A, Sandin A, El-Sharif N, Strachan D, van Hage M, von Mutius E, Brunekreef B, and the ISAAC Phase Two Study Group. Asthma and allergic symptoms in relation to house dust endotoxin: Phase Two of the International Study on Asthma and Allergies in Childhood (ISAAC II). Clin Exp Allergy 2008; 38: 1911–1920.
• View Abstract | View full article [17 citations]

• 2.5 Flohr C, Weinmayr G, Weiland SK (deceased), Addo-Yobo E, Annesi-Maesano I, Björkstén B, Bråbäck L, Büchele G, Chico M, Cooper P, Clausen M, El-Sharif N, Martínez Gimeno A, Mathur RS, von Mutius E, Morales Suárez-Varela MM, Pearce N, Svabe V, Wong GWK, Yu M, Zhong NS, Williams HC and the ISAAC Phase Two Study Group. How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2009; 161(4): 846-853. Epub 27 May.
• View Abstract | View Journal page [8 citations]

• 2.6 Nagel G, Büchele G, Weinmayr G, Björkstén B, Chen Y-Z, Wang H, Nystad W, Saraçlar Y, Bråbäck L, Batllés-Garrido J, García-Hernández G, Weiland SK, and the ISAAC Phase Two Study Group. Effect of Breastfeeding on Asthma, Lung function, and Bronchial Hyperreactivity in ISAAC-Phase-Two. Eur Respir J.2009; 33: 993–1002; Epub 2009 Jan22.
• View Abstract | View full article [11 citations]

• 2.7 Genuneit J, Cantelmo JL, Weinmayr G, Wong GWK, Cooper PJ, Riikjärv MA, Gotua M, Kabesch M, von Mutius E, Forastiere F, Crane J, Nystad W, El Sharif N, Batllés-Garrido J, García-Marcos L, García-Hernández G, Morales Suárez-Varela MM, Nilsson L, Bråbäck L, Saraçlar Y, Weiland SK, Cookson WOC, Strachan DP, Moffatt MF, ISAAC Phase Two Study Group. A multi-centre study of candidate genes for wheeze and allergy. The International Study of Asthma and Allergies in Childhood Phase Two. Clin Exp Allergy 2009 Dec; 39(12): 1875-1888
• View Abstract | View Journal page [9 citations]

• 2.8 Weinmayr G, Genuneit J, Nagel G, Björkstén B, van Hage M, Priftanji A, Cooper P, Rijkjärv M-A, von Mutius E, Tsanakas J, Forastiere F, Doekes G, Garrido JB, Morales Suárez-Varela MM, Bråbäck L, Strachan DP, the ISAAC Phase Two Study Group. International variations in associations of allergic markers and diseases in children: ISAAC Phase Two. Allergy 2010; 65(6): 766–775. epub 21 Dec 2009. DOI:10.1111/j.1398-9995.2009.02283.x
• View Abstract | View Journal page [7 citations]

• 2.9 Nagel G, Weinmayr G, Kleiner A, García-Marcos, Strachan DP, the ISAAC Phase Two Study Group. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax 2010; 65(6): 516-522 doi:10.1136/thx.2009.128256
• View Abstract| View Journal page | View Editorial [13 citations]

• 2.10 Büchele G, Genuneit J, Weinmayr G, Björkstén B, Gehring U, von Mutius E, Priftanji A, Stein RT, Addo-Yobo EO, Priftis KN, Shah JR, Forastiere F, Svabe V, Crane J, Nystad W, García-Marcos L, Saraçlar Y, El-Sharif N, Strachan DP and the ISAAC Phase Two Study Group International Variations in Bronchial Responsiveness in Children: Findings From ISAAC Phase Two Pediatr Pulmonol 2010; 45(8): 796–806
• View Abstract | View Journal page [3 citations]

• 2.11 Flohr C, Nagel G, Weinmayr G, Kleiner A, Strachan DP, Williams HC and the ISAAC Phase Two Study Group Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two Br J Dermatol 2011; 165(6): 1280-1289 Epub 2 Nov. DOI: 10.1111/j.1365-2133.2011.10588.x
• View Abstract| View Journal page | View Editorial

• 2.12 Weinmayr G, Kleiner A, Genuneit J, Weiland S, Forastiere F. Relationship between rhinitis symptoms and allergic sensitization in phase 2 of the International Study of Asthma and Allergies in Childhood (ISAAC). [German] Allergologie 2012; 35(1):11-19
• View Abstract | View Journal page

ISAAC PhaseThree Publications (worldwide)

1.0 Preliminary Papers

• 1.1 Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, on behalf of the ISAAC Steering Committee and the ISAAC Phase Three Study Group. ISAAC Phase Three Manual. Auckland.July 2000.ISBN 0-473-06910-5.
• | View full article

• 1.2 Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, and the ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): Phase Three rationale and methods. Int J Tuberc Lung Dis 2005; 9(1): 10-6.
• View Abstract | View Article | View Editorial [80 citations]

2.0 Main Findings

• 2.1 Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368(9537): 733-743.
• View Abstract | View Journal page [606 citations]

• 2.2 Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, Robertson C, and the ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62(9): 758-66.
• View Abstract| View Article | View Editorial [158 citations]

• 2.3 Björkstén B, Clayton T, Ellwood P, Stewart A, Strachan D, and the ISAAC Phase Three Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008; 19(2): 110-24.
• View Abstract | View full article [50 citations]

• 2.4 Williams H, Stewart A, von Mutius E, Cookson B, Anderson HR, and the ISAAC Phase One and Three Study groups. Is eczema really on the increase worldwide? J Allergy Clin Immunol 2008; 121(4): 947-54.
• View Abstract | View full article [42 citations]

• 2.5 Aït-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J, and the ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64: 123–148.
• View Abstract | View Journal page [29 citations]

• 2.6 Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, and the ISAAC Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476–483.Epub Feb 2009.
• View Abstract | View Journal page | View Editorial [46 citations]

• 2.7 Odhiambo J, Williams H, Clayton T, Robertson C, Asher MI, and the ISAAC Phase Three Study group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three J Allergy Clin Immunol. Dec 2009;124(6):1251-8.
• View Abstract | View Journal page [20 citations]

• 2.8 Asher MI, Stewart AW, Wong G, Strachan DP, García-Marcos L, Anderson HR and the the ISAAC Phase Three Study Group. Changes over time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: A global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC). Allergol Immunopathol (Madr). 2012 Jan 30. [Epub ahead of print]
• View Abstract | View Journal page

3.0 Environmental Questionnaire Analyses

• 3.1 Beasley R, Clayton T, Crane J, von Mutius E, Lai CKW, Montefort S, Stewart A, for the ISAAC Phase Three Study Group. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372(9643): 1039-48.
• View Abstract | View Journal page [76 citations]

• 3.2 Brunekreef B, Stewart AW, Anderson HR, Lai CKW, Pearce NE, and the Phase Three Study Group. Self Reported Truck Traffic on the Street of Residence and Symptoms of Asthma and Allergic Disease: A Global Relationship in ISAAC Phase Three. Environ Health Perspect 2009; 117(11): 1791-98. Epub July 2009.
• View Abstract | View full article [10 citations]

• 3.3 Foliaki S, Pearce N, Björkstén B, Mallol J, Montefort S, von Mutius E and the ISAAC Phase Three Study Group. Antibiotic use in infancy and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6 to 7 year old children: ISAAC Phase Three. J Allergy Clin Immunol 2009;124(5):982-9.
• View Abstract | View Journal page [15 citations]

• 3.4 Beasley RW, Clayton TO, Crane J, Lai CKW, Montefort SR, von Mutius E, Stewart AW, and the ISAAC Phase Three Study Group. Acetaminophen Use and Risk of Asthma, Rhinoconjunctivitis and Eczema in Adolescents: ISAAC Phase Three Am J Resp Crit Care Med. 2011; 183(2): 171-178. epub 13 August 2010
• View Abstract| View Journal page View Editorial [4 citations]

• 3.5 Björkstén B, Aït-Khaled N, Asher MI, Clayton TO, Robertson C, the ISAAC Phase Three Study Group Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6—7 year old children: ISAAC Phase Three. Allergol Immunopathol (Madr). 2011;39(6):318-25. doi:10.1016/j.aller.2011.02.005
• View Abstract| View article | View Editorial

• 3.6 Brunekreef B, von Mutius E, Wong GK, Odhiambo JA, Clayton TO, the ISAAC Phase Three Study Group Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study Int J Epidemiol 2012 Epub ahead of print
• View Abstract| View Journal page | View Editorial

4.0 Other papers

• 4.1 Ellwood P, Williams H, Aït-Khaled N, Björkstén B, Robertson C, and the ISAAC Phase III Study Group. Translation of questions: The International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis.September 2009; 13(9): 1174-1182.
• View Abstract | View full article [7 citations]

• 4.2 Asher MI Recent perspectives on global epidemiology of asthma in childhood Allergol Immunopathol (Madr). 2010; 38(2):83-7.
• View Abstract | View full article [4 citations]

• 4.3 Flohr C. What can we learn about eczema from the International Study of Asthma and Allergies in Childhood (ISAAC)? Allergologie 2010; 33(6): 242–250
• View Abstract | View Journal page [1 citations]

• 4.4 Ellwood P, Asher MI, Stewart AW and the ISAAC Phase III Study Group The impact of the method of consent on response rates in the ISAAC time trends study. Int J Tuberc Lung Dis. 2010 Aug;14(8):1059-65.
• View Abstract | View Journal page | View Editorial [2 citations]

• 4.5 Flohr C. Recent perspectives on the global epidemiology of childhood eczema Allergol Immunopathol (Madr). 2011;39(3):174-182
• View Abstract | View full article

Back